white paper

Harnessing Medical Innovation to Make America Healthy Again

/in /by

Abstract

Join The Heritage Foundation and leading medical scientists for a discussion of cutting edge medical technology and its wider implementation to make Americans healthier. Photobiomodulation (PBM) and hyperbaric oxygen therapy (HBOT) are two proven treatments that stimulate cell growth in patients suffering from a vast array of conditions. Managing pain, promoting wound healing, and treating brain injuries are just a few of the applications for these treatments.

 

Read More on heritage.org or download the PDF.

white paper

Photobiomodulation Clinic at Mass General Offers a Promising New Treatment for Neuropsychiatric Disorders

/in /by

Abstract

Transcranial photobiomodulation (PBM) is emerging as an innovative approach to treat various neuropsychiatric conditions, including major depressive disorder, generalized anxiety disorder, traumatic brain injury, and Alzheimer’s disease and other types of dementia. The Brain Photobiomodulation Clinic at Mass General Hospital, under the direction of Paolo Cassano, MD, PhD, offers this cutting-edge treatment for patients with treatment-resistant neuropsychiatric disorders.

 

Read More on mghpsychnews.org or download the PDF.

white paper

Lighting the Way to a Healthier America

/in /by

Abstract

The Make America Healthy Again (MAHA) movement is now national policy with Trump establishing the MAHA Commission and Robert F. Kennedy, Jr. as the Secretary of the Department of Health & Human Services (HHS).

Americans are universally concerned about their health, but well-financed and entrenched interests are thwarting MAHA. Big Pharma spends $400 million a year on lobbying and contributes $90 million each election cycle. Big food spends $130 million a year on lobbying and contributes $42.5 million each election cycle.

 

Read More on citizenoversight.blogspot.com or download the PDF.

white paper

Local athletes to be subjects of new, international study

/in /by

Abstract

SHEPHERDSTOWN — Athletes from Shepherd University will soon be some of the subjects of a new study being conducted by photobiomodulation (PBM) therapy researchers.

According to Ann Liebert, who is the coordinator of photomolecular research at Sydney Adventist Hospital in Australia, the research will focus on whether or not PBM therapy heals concussions.

 

Read More on journal-news.net or download the PDF.

white paper

Military Explores Light Therapy for Brain Injuries

/in /by

Abstract

The U.S. Department of Defense (DOD) is taking steps to explore how noninvasive, nondrug light therapy can help military members and veterans recover from traumatic brain injuries (TBI).

 

Read More on heartlanddailynews.com or download the PDF

white paper

Poulsbo firm gets FDA OK to treat common eye problem

/in /by

Abstract

Clark Tedford has been smiling so much he said his jaw is starting to hurt.

He has good reason to be happy – his company, Lumithera in Poulsbo, a family-owned medical device company, recently received word that the Food and Drug Administration has approved their new product, Valeda, a non-invasive treatment for degenerative eye disease.

“The target we’re going after, age-related macular degeneration, is the largest cause of vision loss in adults over the age of 65,” said Tedford, who has a doctorate in pharmacology. “There aren’t a lot of alternatives for these patients, and over years they’ll lose their vision slowly, and it can be devastating.”

Read More on kitsapdailynews.com or download the PDF.

white paper

LumiThera Receives FDA Authorization for Valeda Treatment for Dry AMD

/in /by

Abstract

The U.S. FDA has granted LumiThera authorization to market its Valeda Light Delivery System, the first FDA-authorized device designed to treat vision loss in patients with dry age-related macular degeneration (AMD). This significant approval, obtained through the De Novo authorization pathway, marks a major milestone in noninvasive treatments for dry AMD.

 

Read More on ophthalmologybreakingnews.com or download the PDF.

white paper

Red Light Therapy: Benefits For Athletic Performance, Recovery, And Pain Relief

/in /by

Abstract

You’ve seen the celebrities and influencers donning futuristic LED face masks to improve signs of aging and acne. The technology behind it—red light therapy(RLT), which is a form of photobiomodulation, as scientists say—has potential perks that are more than skin-deep.

Elite athletes, for example, hop into specialized red light beds to speed up recovery time. Doctors use it as an adjunct treatment for patients with chronic and acute pain and are hopeful it may help curb the amount of opioids they prescribe post-op.

Read More on womenshealthmag.com or Download the PDF

white paper

Shepherd University study shows promise in treating opioid disorder with light therapy

/in /by

Abstract

SHEPHERDSTOWN, W.Va. — A Shepherd University study on the use of light therapy to combat opioid addiction has been accepted for publication in the esteemed journal Photobiomodulation, Photomedicine, and Laser Surgery.

The pilot study focuses on using photobiomodulation (PBM) in the treatment of opioid use disorder.

The study, co-authored by Drs. Jennifer Flora and Kelly Watson Huffer, examines the impact of  PBM on “reducing opioid cravings and depressive symptoms among individuals undergoing treatment for opioid addiction.”

Read More on wvmetronews.com or download the PDF.

white paper

Photobiomodulation And The Aging Brain – How Can Near Infrared Light Impact Neurodegenerative Diseases?

/in /by
By Chris Gallagher |usatoday.com | January 17, 2024
Here’s the good news: we’re living longer. The WHO reports that global life expectancy “increased by more than six years between 2000 and 2019.” Of the many reasons that this number is going up, advances in medicine top the list. 
 Read Online»  |  Download PDF»